Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,

L. Shinto, G. Marracci, S. Baldauf-Wagner, A. Strehlow, V. Yadav, L. Stuber, D. Bourdette

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Objectives: The primary objective was to evaluate the effect of omega-3 fatty acids (omega-3 FA) on matrix metalloproteinase-9 (MMP-9) production by immune cells in multiple sclerosis (MS). Quality of life, fatty acid levels, and safety were also evaluated. Materials and Methods: Ten participants with relapsing-remitting MS (RRMS) received omega-3 FA supplementation (9.6 g/day fish oil) in an open-label study. Participants were evaluated at four time points, baseline, after 1 month of omega-3 FA supplementation, after 3 months of omega-3 FA supplementation, and after a 3-month wash out. Results: Immune cell secretion of MMP-9 decreased by 58% after 3 months of omega-3 FA supplementation when compared with baseline levels (p<0.01). This effect was coupled with a significant increase in omega-3 FA levels in red blood cell membranes. Conclusions: Omega-3 FA significantly decreased MMP-9 levels in RRMS and may act as an immune-modulator that has potential therapeutic benefit in MS patients.

Original languageEnglish (US)
Pages (from-to)131-136
Number of pages6
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume80
Issue number2-3
DOIs
StatePublished - Feb 2009

Keywords

  • Matrix metalloproteinase
  • Multiple sclerosis
  • Omega-3 fatty acids

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology

Fingerprint Dive into the research topics of 'Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis<sup>,</sup>'. Together they form a unique fingerprint.

Cite this